Atlas Trials

Evaluation of the Efficacy of Novel Biomarkers in Predicting Clopidogrel Resistance in Patients with Ischemic Stroke

Clinical trial NCT06753149 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06753149
Sponsor
Nanjing First Hospital, Nanjing Medical University
Status
NOT_YET_RECRUITING
Study type
OBSERVATIONAL
Ischemic StrokeTIA (Transient Ischemic Attack)Clopidogrel Resistance
Start date
2025-02-01
Primary completion
2026-03-31
Enrollment
800

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.